Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-05-22

Clinical Trial Update: A Feasibility Trial to Evaluate the Senseonics Continuous Glucose Monitoring System in Canada [NA]

View source ↗

Summary

Feasibility trial update for the Senseonics continuous glucose monitoring system in Canada evaluating its use in diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Senseonics Continuous Glucose Monitoring System

Snippet

Sponsor: Senseonics, Inc. | Conditions: Diabetes Mellitus | NA | Status: UNKNOWN